SARS-CoV-2
E335284
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
All labels observed (6)
| Label | Occurrences |
|---|---|
| SARS-CoV-2 canonical | 17 |
| Severe acute respiratory syndrome coronavirus 2 | 4 |
| COVID-19 | 1 |
| SARS2 | 1 |
| SARS‑CoV‑2 | 1 |
| Severe acute respiratory syndrome-related coronavirus | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3205316 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 Context triple: [COVID-19 pandemic, hasCauseAgent, SARS-CoV-2]
-
A.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
B.
Ad26.COV2.S
Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.
-
C.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
D.
RSV
RSV is a widely used mid-20th-century English translation of the Bible that sought to update archaic language while retaining a traditional literary style.
-
E.
BRSV
BRSV is the National Rail station code for Race–Vine station in Philadelphia, Pennsylvania.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 Target entity description: SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
A.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
B.
Ad26.COV2.S
Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.
-
C.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
D.
RSV
RSV is a widely used mid-20th-century English translation of the Bible that sought to update archaic language while retaining a traditional literary style.
-
E.
BRSV
BRSV is the National Rail station code for Race–Vine station in Philadelphia, Pennsylvania.
- F. None of above. chosen
Statements (54)
| Predicate | Object |
|---|---|
| instanceOf |
betacoronavirus
ⓘ
coronavirus ⓘ enveloped virus ⓘ positive-sense single-stranded RNA virus ⓘ zoonotic virus ⓘ |
| abbreviation |
SARS2
ⓘ
linked to:
SARS-CoV-2
|
| associatedDisease | severe acute respiratory syndrome ⓘ |
| BaltimoreClassification | Group IV ⓘ |
| biosafetyLevel | BSL-3 ⓘ |
| canCause |
acute respiratory distress syndrome
ⓘ
loss of smell ⓘ loss of taste ⓘ multi-organ failure ⓘ pneumonia ⓘ |
| causes |
COVID-19
ⓘ
linked to:
COVID-19 pandemic
|
| declaredPublicHealthEmergencyBy | World Health Organization ⓘ |
| family |
Coronaviridae
ⓘ
linked to:
Riboviria
|
| firstDetectedIn | Wuhan ⓘ |
| firstDetectedInCountry | China ⓘ |
| firstDetectionDate | 2019-12 ⓘ |
| fullName |
Severe acute respiratory syndrome coronavirus 2
ⓘ
linked to:
SARS-CoV-2
|
| genomeLength | approximately 29.9 kilobases ⓘ |
| genomeSegmentation | non-segmented ⓘ |
| genomeSense | positive-sense ⓘ |
| genomeStrandedness | single-stranded ⓘ |
| genomeType | RNA ⓘ |
| genus | Betacoronavirus ⓘ |
| hasProtein |
accessory proteins
ⓘ
envelope protein ⓘ membrane protein ⓘ non-structural proteins ⓘ nucleocapsid protein ⓘ spike glycoprotein ⓘ |
| hasVariant |
Alpha variant
ⓘ
Beta variant ⓘ Delta variant ⓘ Gamma variant ⓘ Omicron variant ⓘ |
| host |
bat
ⓘ
human ⓘ |
| inactivatedBy |
alcohol-based disinfectant
ⓘ
soap ⓘ |
| order | Nidovirales ⓘ |
| parentTaxon |
Severe acute respiratory syndrome-related coronavirus
ⓘ
linked to:
SARS-CoV-2
|
| preventedBy |
COVID-19 vaccine
ⓘ
linked to:
COVID-19 vaccines
|
| primaryInfectionSite | respiratory tract ⓘ |
| receptorUsedForEntry | ACE2 ⓘ |
| relatedTo |
MERS-CoV
ⓘ
SARS-CoV ⓘ |
| subfamily |
Orthocoronavirinae
ⓘ
linked to:
Nidovirales
|
| taxonRank | species ⓘ |
| transmissionRoute |
aerosols
ⓘ
contact with contaminated surfaces ⓘ respiratory droplets ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: SARS-CoV-2 Description of subject: SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
Referenced by (25)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject linked to:
human adenovirus serotype 26 (Ad26)
linked to: SARS-CoV-2
linked to: SARS-CoV-2
linked to: SARS-CoV-2
linked to: SARS-CoV-2
linked to: SARS-CoV-2
linked to: SARS-CoV-2
subject linked to:
Sinovac
linked to: SARS-CoV-2
linked to: SARS-CoV-2